Cd40 Protein Cluster Of Differentiation 40 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Symbol | CD40 |
| Protein Name | Cluster of Differentiation 40 |
| Molecular Weight | 48 kDa (glycosylated) |
| Protein Family | TNF Receptor Superfamily |
| Ligand | CD40L (CD154) |
| Associated Diseases | AD, PD, ALS, MS, Atherosclerosis, Autoimmune Disorders |
CD40 (Cluster of Differentiation 40) is a cell surface receptor belonging to the TNF (Tumor Necrosis Factor) receptor superfamily. It plays a pivotal role in immune cell activation and communication, particularly in the interaction between T cells and B cells, antigen-presenting cells, and endothelial cells. In the central nervous system, CD40 is expressed on microglia, astrocytes, and neurons, where it mediates neuroinflammatory responses and participates in the pathogenesis of neurodegenerative diseases.
CD40 is a 48 kDa type I transmembrane glycoprotein:
CD40 is upregulated in AD brain, particularly in microglia surrounding amyloid plaques. CD40-CD40L signaling promotes:
Therapeutic approaches include CD40-Fc fusion proteins and CD40L blocking antibodies.
Elevated CD40 in PD substantia nigra and CSF. The receptor contributes to:
CD40 expression increased in ALS spinal cord microglia. Contributes to neuroinflammation and disease progression. CD40 deficiency in mouse models shows reduced microglial activation.
Central role in demyelination and lesion formation. CD40-CD40L blockade reduces disease severity in EAE (experimental autoimmune encephalomyelitis).
CD40 signaling promotes plaque inflammation and instability. CD40 inhibitors reduce atherosclerosis in models.
| Approach | Status | Description |
|---|---|---|
| CD40-Fc fusion | Preclinical | Soluble receptor decoy |
| Anti-CD40L antibodies | Clinical (autoimmune) | Blocking CD40-CD40L interaction |
| TRAF inhibitors | Preclinical | Downstream signaling blockers |
| Small molecule inhibitors | Research | Targeting receptor-ligand interaction |
The study of Cd40 Protein Cluster Of Differentiation 40 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.